Laxmi Dental

Laxmi Dental

346.60
-0.25
(-0.07%)
Market Cap
1,906.40 Cr
EPS
6.06
PE Ratio
82.54
Dividend Yield
0.00 %
Industry
Healthcare
52 Week High
584.00
52 Week Low
302.00
PB Ratio
9.16
Debt to Equity
1.47
Add Ratio
hide

Investment Returns

In Long Term
In Short Term
1 Year
0.00%
2 Years
0.00%
3 Years
0.00%
4 Years
0.00%
5 Years
0.00%
Analyst Rating
- By Refinitiv from3 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %

Company News

View All News
Caret
positive
Laxmi Dental Limited has completed its acquisition of stakes in IDBG AI Dent Global Private Limited. The company received 11,175 equity shares at ₹10 face value with a premium of ₹1,217.5 per share for ₹1.37 crore, securing a 49% equity stake. Additionally, it acquired 5,123 compulsorily convertible preference shares at the same pricing for ₹62.88 lakh, representing a 9% preference share stake. The transaction, originally announced in July 2025, is now complete following the receipt of share certificates from IDBG AI Dent Global Private Limited.
positive
Laxmi Dental Reports Record Quarterly Revenue of Rs 65.6 Crores, Up 10% YoYAug 19, 2025
Laxmi Dental Limited achieved its highest ever quarterly revenue of Rs 65.6 crores in Q1 FY26, representing a 10% year-over-year increase from Rs 59.7 crores. The company reported EBITDA of Rs 11.9 crores with an 18.2% margin and PAT of Rs 8.3 crores with a 12.7% margin. The dental laboratory segment contributed 59% of revenue with 8% growth, while aligner solutions accounted for 28% of revenue with 18% growth. Scanner sales grew 26% year-over-year, with units sold increasing from 80+ in Q1 FY25 to over 200 units. The company has fully repaid its debt using IPO proceeds and made a strategic investment in AI-focused dental startup IDBG AI Dent Global. Management expects 20-25% revenue growth for FY26 and plans to deploy 1,000 scanners during the current financial year. The company faces challenges from 25% US tariffs on exports and pricing pressure in the B2B2C aligner business.
neutral
Laxmi Dental Limited Makes Q1FY26 Earnings Call Audio Recording Available on Company WebsiteAug 13, 2025
Laxmi Dental Limited has made the audio recording of their Q1FY26 Earnings Conference Call available on their company website. The call was held on August 13, 2025, at 12:00 Noon (IST) and was organized by Motilal Oswal Financial Services Limited. The company informed BSE Limited and National Stock Exchange of India Limited about the availability of the recording through a formal communication. The audio recording can be accessed through a direct link provided on the company's website. This disclosure was made in compliance with applicable listing regulations.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,996.20
#1 20,927.80
58.41
#1 1,759.00
22.62
#1 339
25.81
55.55
346.60
#2 1,906.40
#9 82.54
#4 236.56
#6 19.23
#3 29
#5 -50.60
48.97
309.15
1,667.50
60.54
408.40
-0.45
30
-55.00
32.02
636.45
1,047.40
52.24
186.60
#1 61.83
20
-
76.45
632.45
1,042.80
63.95
249.37
40.00
17
-20.59
55.13
564.00
685.40
36.28
67.10
30.58
18
18.92
49.88
278.80
538.20
#1 33.41
136.30
-
16
-
72.78
359.80
383.30
48.43
111.80
-1.43
8
-0.10
96.11
280.20
296.90
37.11
89.85
0.60
7
#1 752.54
53.71
252.43
252.40
-
122.10
19.24
1
-52.94
50.97
Forecast
Actual
Growth Rate
Revenue Growth
19.23 %
Net Income Growth
-506.82 %
Cash Flow Change
-43.56 %
ROE
-276.23 %
ROCE
-4,748.84 %
EBITDA Margin (Avg.)
91.50 %

Quarterly Financial Results

Quarterly Financials
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Revenue
48
55
66
57
61
63
66
Expenses
44
44
46
48
52
51
54
EBITDA
3
11
20
9
9
11
12
Operating Profit %
6 %
19 %
22 %
14 %
14 %
15 %
17 %
Depreciation
3
3
3
3
4
4
4
Interest
1
1
1
1
2
1
1
Profit Before Tax
-1
7
16
5
5
6
10
Tax
-3
-1
-1
-1
-0
2
1
Net Profit
2
8
17
6
5
4
8
EPS in ₹
76.30
1.46
3.24
2.12
0.88
0.79
1.53

Balance Sheet

Balance Sheet
2020
2021
2022
2023
2024
2025
Total Assets
106
106
103
97
135
285
Fixed Assets
39
43
40
40
46
51
Current Assets
53
50
60
53
64
187
Capital Work in Progress
0
7
0
0
0
0
Investments
0
0
0
0
6
19
Other Assets
66
57
63
56
83
0
Total Liabilities
106
106
103
97
135
285
Current Liabilities
46
46
59
57
67
57
Non Current Liabilities
11
15
20
20
23
19
Total Equity
49
44
23
20
45
209
Reserve & Surplus
37
33
9
6
31
198
Share Capital
12
12
0
0
0
11

Cash Flow

Cash Flow
2020
2021
2022
2023
2024
Net Cash Flow
0
0
-3
4
-6
Investing Activities
-18
-9
3
-10
-15
Operating Activities
12
10
-2
14
8
Financing Activities
6
-0
-4
-2
1

Share Holding

% Holding
Sept 2024
Jan 2025
Mar 2025
Jun 2025
Promoter
86.61 %
41.70 %
41.70 %
41.70 %
FIIs
0.00 %
29.49 %
34.24 %
33.59 %
DIIs
0.00 %
15.18 %
12.86 %
14.31 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
0.00 %
9.56 %
6.49 %
5.80 %
Others
13.39 %
4.07 %
4.70 %
4.60 %
No of Share Holders
13
13
29,482
27,957

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
29 Sept 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
29 Sept 2025 333.60 346.85
13 Feb 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
13 Feb 2025 481.80 429.60
26 May 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
26 May 2025 394.40 393.80
12 Aug 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
12 Aug 2025 410.75 391.55

Announcements

Announcement under Regulation 30 (LODR)-Updates on Acquisition3 hours ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation4 hours ago
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 08, 2025
Reg. 34 (1) Annual Report.Sep 06, 2025
Intimation Of 21St Annual General Meeting (AGM) Of The Company Scheduled To Be Held On Monday September 29 2025.Sep 06, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationSep 05, 2025
Disclosure Under SEBI (Share Based Employee Benefits And Sweat Equity) Regulations 2021 - Modification Of ESOP Scheme.Aug 29, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 29, 2025
Board Meeting Outcome for Outcome Of Board Of Directors Meeting Held Today I.E. Friday August 29 2025.Aug 29, 2025
Intimation Under Regulation 30 Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 29, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 28, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptAug 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 18, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationAug 14, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeAug 13, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseAug 12, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationAug 12, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportAug 12, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementAug 12, 2025
Financial Results For The Quarter Ended 30Th June 2025.Aug 12, 2025
Board Meeting Outcome for Outcome Of Board Of Directors Meeting Held On Tuesday August 12 2025.Aug 12, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 07, 2025
Board Meeting Intimation for Consideration And Approval Of Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2025.Aug 07, 2025
Board Comments On Fine Levied By The National Stock Exchange Of India Limited For Non-Compliance With Regulation 23(9) Of The SEBI (LODR) Regulations 2015.Jul 28, 2025
Announcement under Regulation 30 (LODR)-AcquisitionJul 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 08, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 07, 2025
Closure of Trading WindowJun 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 23, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 17, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJun 12, 2025
Announcement under Regulation 30 (LODR)-Resignation of DirectorJun 06, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 30, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptMay 30, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 28, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeMay 27, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseMay 27, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationMay 27, 2025
Announcement under Regulation 30 (LODR)-Change in ManagementMay 27, 2025
Financial Results For The Financial Year Ended 31St March 2025May 27, 2025
Board Meeting Outcome for Outcome Of Board Of Directors Meeting Of Laxmi Dental Limited Held On Monday May 26 2025May 27, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationMay 21, 2025
Board Meeting Intimation for Consideration And Approval Of Audited Financial Results (Standalone And Consolidated) For The Quarter And Financial Year Ended March 31 2025.May 21, 2025
Shareholder Meeting / Postal Ballot-Scrutinizer"s ReportMay 20, 2025
Announcement under Regulation 30 (LODR)-Monitoring Agency ReportMay 15, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionApr 29, 2025
Announcement under Regulation 30 (LODR)-AcquisitionApr 28, 2025
Announcement under Regulation 30 (LODR)-Updates on AcquisitionApr 24, 2025

Technical Indicators

RSI(14)
Neutral
48.97
ATR(14)
Less Volatile
16.77
STOCH(9,6)
Neutral
40.14
STOCH RSI(14)
Overbought
90.80
MACD(12,26)
Bullish
5.89
ADX(14)
Strong Trend
32.67
UO(9)
Bearish
44.49
ROC(12)
Uptrend And Accelerating
3.08
WillR(14)
Neutral
-40.24

Mutual Fund Holdings

Funding HouseCurrent Holding %1M Change1M Change %3M Change %Last 6M Trend
Invesco India Smallcap Fund Direct - Growth
0.18%
-362553
-0.25%
-0.50%
TRUSTMF Small Cap Fund Direct-Growth
0.74%
-72586
-0.47%
-0.24%
Aditya Birla Sun Life Small Cap Fund Direct-Growth
0.12%
-42397
-0.06%
-0.24%
LIC MF Focused Fund Direct - Growth
1.54%
22341
0.18%
1.54%
WhiteOak Capital Pharma and Healthcare Fund Direct - Growth
0.24%
-11338
-0.18%
-0.45%
Quant Healthcare Fund Direct - Growth
2.55%
-2881
-0.44%
-0.41%
Mirae Asset Healthcare Fund Direct - Growth
0.50%
0
-0.09%
-0.14%
Bank of India Small Cap Fund Direct-Growth
0.82%
0
-0.17%
-0.20%
HDFC Pharma And Healthcare Fund Direct - Growth
1.15%
0
-0.25%
-0.42%
HSBC Consumption Fund Direct - Growth
0.53%
0
-0.14%
-0.17%
HSBC India Export Opportunities Fund Direct-Growth
0.91%
0
-0.17%
-0.30%
ICICI Prudential Pharma Healthcare and Diagnostics (P.H.D) Fund Direct - Growth
0.00%
0
0.00%
0.00%
Edelweiss Recently Listed IPO Fund Direct-Growth
0.00%
0
0.00%
0.00%
Kotak Consumption Fund Direct - Growth
0.60%
0
-0.21%
-0.26%
Kotak Healthcare Fund Direct - Growth
1.53%
0
-0.30%
-0.48%
DSP Healthcare Fund Direct - Growth
0.31%
0
-0.06%
-0.09%
Aditya Birla Sun Life Manufacturing Equity Fund Direct-Growth
0.27%
0
-0.06%
-0.06%
Quant Dynamic Asset Allocation Fund Direct - Growth
1.14%
0
-0.20%
-0.22%
Quant Flexi Cap Fund Direct-Growth
0.25%
0
-0.05%
-0.04%
HDFC Non-Cyclical Consumer Fund Direct - Growth
0.36%
0
-0.10%
-0.12%
Quant Manufacturing Fund Direct - Growth
0.93%
0
-0.15%
-0.12%
Quant Small Cap Fund Direct Plan-Growth
0.02%
0
0.00%
0.00%
Tata ELSS Fund Direct-Growth
0.21%
0
-0.05%
-0.05%
Tata India Innovation Fund Direct-Growth
0.10%
0
-0.02%
-0.02%
Tata India Pharma & Healthcare Fund Direct-Growth
0.04%
0
-0.01%
-0.01%